Supplementary Table S5. The significant GO terms enriched by the genes that were significant correlated with CTC positive group.,,,,,,,,,
,ID,Description,GeneRatio,BgRatio,pvalue,p.adjust,qvalue,geneID,Count
GO:0043312,GO:0043312,neutrophil degranulation,21/191,485/18670,2.78E-08,3.69E-05,3.16E-05,TMC6/RNASE2/ATG7/CD68/CHIT1/CLEC5A/CYBB/GM2A/MPO/PRG2/BST1/CD93/CRISPLD2/FCAR/FPR1/HPSE/LILRB2/MGAM/MME/S100A12/SIGLEC5,21
GO:0002283,GO:0002283,neutrophil activation involved in immune response,21/191,488/18670,3.10E-08,3.69E-05,3.16E-05,TMC6/RNASE2/ATG7/CD68/CHIT1/CLEC5A/CYBB/GM2A/MPO/PRG2/BST1/CD93/CRISPLD2/FCAR/FPR1/HPSE/LILRB2/MGAM/MME/S100A12/SIGLEC5,21
GO:0042119,GO:0042119,neutrophil activation,21/191,498/18670,4.38E-08,3.69E-05,3.16E-05,TMC6/RNASE2/ATG7/CD68/CHIT1/CLEC5A/CYBB/GM2A/MPO/PRG2/BST1/CD93/CRISPLD2/FCAR/FPR1/HPSE/LILRB2/MGAM/MME/S100A12/SIGLEC5,21
GO:0002446,GO:0002446,neutrophil mediated immunity,21/191,499/18670,4.53E-08,3.69E-05,3.16E-05,TMC6/RNASE2/ATG7/CD68/CHIT1/CLEC5A/CYBB/GM2A/MPO/PRG2/BST1/CD93/CRISPLD2/FCAR/FPR1/HPSE/LILRB2/MGAM/MME/S100A12/SIGLEC5,21
GO:0071621,GO:0071621,granulocyte chemotaxis,10/191,123/18670,5.47E-07,0.000356818,0.000305339,PF4/THBS1/SCG2/BST1/CSF3R/DYSF/PDE4B/S100A12/CXCL13/IL17RA,10
GO:0050680,GO:0050680,negative regulation of epithelial cell proliferation,11/191,165/18670,1.08E-06,0.000585892,0.000501364,MEF2C/KLF9/RUNX3/THBS1/PPARG/VASH1/APOE/SCG2/CAV1/NFIB/ATF2,11
GO:0097530,GO:0097530,granulocyte migration,10/191,141/18670,1.92E-06,0.000894966,0.000765847,PF4/THBS1/SCG2/BST1/CSF3R/DYSF/PDE4B/S100A12/CXCL13/IL17RA,10
GO:0015718,GO:0015718,monocarboxylic acid transport,10/191,163/18670,7.06E-06,0.002616342,0.002238875,ABCB4/SLC16A7/ACACB/THBS1/PPARG/SLC26A6/APOE/PLA2G6/NTSR1/SLC6A8,10
GO:0050870,GO:0050870,positive regulation of T cell activation,11/191,202/18670,7.67E-06,0.002616342,0.002238875,EBI3/RUNX3/ZBTB16/CD209/HES1/LILRB2/CAV1/IGF2/CYLD/PDCD1/CTLA4,11
GO:0032496,GO:0032496,response to lipopolysaccharide,14/191,330/18670,8.02E-06,0.002616342,0.002238875,MEF2C/PF4/CD68/SGMS1/HPGD/MAOB/MPO/ALPL/LILRB2/PDE4B/TBXA2R/FOXP1/CXCL13/GGT1,14
GO:0002237,GO:0002237,response to molecule of bacterial origin,14/191,343/18670,1.24E-05,0.003144867,0.002691148,MEF2C/PF4/CD68/SGMS1/HPGD/MAOB/MPO/ALPL/LILRB2/PDE4B/TBXA2R/FOXP1/CXCL13/GGT1,14
GO:0001937,GO:0001937,negative regulation of endothelial cell proliferation,7/191,76/18670,1.27E-05,0.003144867,0.002691148,MEF2C/THBS1/PPARG/VASH1/APOE/SCG2/CAV1,7
GO:0022409,GO:0022409,positive regulation of cell-cell adhesion,12/191,255/18670,1.30E-05,0.003144867,0.002691148,EBI3/RUNX3/ZBTB16/CD209/HES1/LILRB2/CAV1/IGF2/CYLD/CXCL13/PDCD1/CTLA4,12
GO:0007611,GO:0007611,learning or memory,12/191,256/18670,1.35E-05,0.003144867,0.002691148,MEF2C/SYNJ1/CTNS/APOE/GM2A/LILRB2/MME/PLA2G6/NTSR1/NFATC4/DGKI/ADCY1,12
GO:1903039,GO:1903039,positive regulation of leukocyte cell-cell adhesion,11/191,218/18670,1.57E-05,0.003415737,0.002922939,EBI3/RUNX3/ZBTB16/CD209/HES1/LILRB2/CAV1/IGF2/CYLD/PDCD1/CTLA4,11
GO:0045785,GO:0045785,positive regulation of cell adhesion,15/191,403/18670,1.80E-05,0.003661272,0.00313305,EBI3/RUNX3/ZBTB16/CD209/HES1/FN1/DYSF/LILRB2/CAV1/TPM1/IGF2/CYLD/CXCL13/PDCD1/CTLA4,15
GO:0010633,GO:0010633,negative regulation of epithelial cell migration,8/191,114/18670,2.26E-05,0.004149734,0.00355104,MEF2C/THBS1/PPARG/TACSTD2/VASH1/APOE/TBXA2R/CXCL13,8
GO:0006836,GO:0006836,neurotransmitter transport,12/191,270/18670,2.29E-05,0.004149734,0.00355104,MEF2C/VAMP2/SYNJ1/SYT17/MAOB/SLC18A2/NTSR1/SLC6A8/ICA1/DGKI/SYNGR3/ADCY1,12
GO:1901654,GO:1901654,response to ketone,10/191,193/18670,3.07E-05,0.005265597,0.004505915,ABCB4/KLF9/ABHD2/THBS1/PPARG/CYBB/MAOB/TBXA2R/CAV1/ADCY1,10
GO:0050678,GO:0050678,regulation of epithelial cell proliferation,14/191,378/18670,3.63E-05,0.005295679,0.004531657,MEF2C/KLF9/RUNX3/HES1/THBS1/PPARG/TACSTD2/VASH1/APOE/SCG2/DYSF/CAV1/NFIB/ATF2,14
GO:0090303,GO:0090303,positive regulation of wound healing,6/191,61/18670,3.69E-05,0.005295679,0.004531657,THBS1/HPSE/TBXA2R/MYLK/F12/HBEGF,6
GO:0046942,GO:0046942,carboxylic acid transport,13/191,331/18670,3.81E-05,0.005295679,0.004531657,ABCB4/SLC16A7/VAMP2/ACACB/THBS1/CTNS/PPARG/SLC26A6/APOE/PLA2G6/NTSR1/SLC6A8/SLC7A10,13
GO:0002696,GO:0002696,positive regulation of leukocyte activation,14/191,380/18670,3.85E-05,0.005295679,0.004531657,EBI3/MEF2C/RUNX3/ZBTB16/CD209/HES1/THBS1/BST1/LILRB2/CAV1/IGF2/CYLD/PDCD1/CTLA4,14
GO:0015849,GO:0015849,organic acid transport,13/191,333/18670,4.05E-05,0.005295679,0.004531657,ABCB4/SLC16A7/VAMP2/ACACB/THBS1/CTNS/PPARG/SLC26A6/APOE/PLA2G6/NTSR1/SLC6A8/SLC7A10,13
GO:0051251,GO:0051251,positive regulation of lymphocyte activation,13/191,334/18670,4.18E-05,0.005295679,0.004531657,EBI3/MEF2C/RUNX3/ZBTB16/CD209/HES1/BST1/LILRB2/CAV1/IGF2/CYLD/PDCD1/CTLA4,13
GO:0050673,GO:0050673,epithelial cell proliferation,15/191,434/18670,4.22E-05,0.005295679,0.004531657,MEF2C/KLF9/RUNX3/HES1/THBS1/PPARG/TACSTD2/VASH1/APOE/COL8A2/SCG2/DYSF/CAV1/NFIB/ATF2,15
GO:0015711,GO:0015711,organic anion transport,16/191,495/18670,5.20E-05,0.006282355,0.005375982,ABCB4/OSBPL10/SLC16A7/VAMP2/ACACB/THBS1/CTNS/PPARG/SLC26A6/APOE/SCARB2/PLA2G6/NTSR1/SLC6A8/SLC7A10/ATP9A,16
GO:0050890,GO:0050890,cognition,12/191,296/18670,5.61E-05,0.006393133,0.005470778,MEF2C/SYNJ1/CTNS/APOE/GM2A/LILRB2/MME/PLA2G6/NTSR1/NFATC4/DGKI/ADCY1,12
GO:0050867,GO:0050867,positive regulation of cell activation,14/191,394/18670,5.69E-05,0.006393133,0.005470778,EBI3/MEF2C/RUNX3/ZBTB16/CD209/HES1/THBS1/BST1/LILRB2/CAV1/IGF2/CYLD/PDCD1/CTLA4,14
GO:0010596,GO:0010596,negative regulation of endothelial cell migration,7/191,97/18670,6.21E-05,0.00659156,0.005640577,MEF2C/THBS1/PPARG/VASH1/APOE/TBXA2R/CXCL13,7
GO:0097529,GO:0097529,myeloid leukocyte migration,10/191,210/18670,6.27E-05,0.00659156,0.005640577,PF4/THBS1/SCG2/BST1/CSF3R/DYSF/PDE4B/S100A12/CXCL13/IL17RA,10
GO:0019915,GO:0019915,lipid storage,6/191,68/18670,6.85E-05,0.006980744,0.005973612,ACACB/PPARG/APOE/GM2A/DYSF/CAV1,6
GO:0015909,GO:0015909,long-chain fatty acid transport,6/191,69/18670,7.44E-05,0.007351457,0.006290842,ACACB/THBS1/PPARG/APOE/PLA2G6/NTSR1,6
GO:0030593,GO:0030593,neutrophil chemotaxis,7/191,104/18670,9.67E-05,0.009162507,0.007840607,PF4/BST1/CSF3R/DYSF/PDE4B/S100A12/CXCL13,7
GO:0050863,GO:0050863,regulation of T cell activation,12/191,314/18670,9.83E-05,0.009162507,0.007840607,EBI3/ZEB1/RUNX3/ZBTB16/CD209/HES1/LILRB2/CAV1/IGF2/CYLD/PDCD1/CTLA4,12
GO:0030595,GO:0030595,leukocyte chemotaxis,10/191,224/18670,0.000107113,0.009702689,0.008302855,PF4/THBS1/SCG2/BST1/CSF3R/DYSF/PDE4B/S100A12/CXCL13/IL17RA,10
GO:1903036,GO:1903036,positive regulation of response to wounding,6/191,74/18670,0.000110206,0.009712981,0.008311661,THBS1/HPSE/TBXA2R/MYLK/F12/HBEGF,6
GO:0048844,GO:0048844,artery morphogenesis,6/191,76/18670,0.000127877,0.010845702,0.009280962,HES1/APOE/HPGD/COL3A1/MYLK/HEY1,6
GO:0030194,GO:0030194,positive regulation of blood coagulation,4/191,26/18670,0.000133035,0.010845702,0.009280962,THBS1/HPSE/TBXA2R/F12,4
GO:1900048,GO:1900048,positive regulation of hemostasis,4/191,26/18670,0.000133035,0.010845702,0.009280962,THBS1/HPSE/TBXA2R/F12,4
GO:0061041,GO:0061041,regulation of wound healing,8/191,148/18670,0.000144064,0.011444769,0.0097936,THBS1/APOE/HPSE/TBXA2R/CAV1/MYLK/F12/HBEGF,8
GO:0000188,GO:0000188,inactivation of MAPK activity,4/191,27/18670,0.000154928,0.011444769,0.0097936,DUSP2/DUSP4/CAV1/DUSP5,4
GO:0050820,GO:0050820,positive regulation of coagulation,4/191,27/18670,0.000154928,0.011444769,0.0097936,THBS1/HPSE/TBXA2R/F12,4
GO:0030193,GO:0030193,regulation of blood coagulation,6/191,79/18670,0.000158522,0.011444769,0.0097936,THBS1/APOE/HPSE/TBXA2R/CAV1/F12,6
GO:0043537,GO:0043537,negative regulation of blood vessel endothelial cell migration,6/191,79/18670,0.000158522,0.011444769,0.0097936,MEF2C/THBS1/PPARG/VASH1/APOE/TBXA2R,6
GO:0002683,GO:0002683,negative regulation of immune system process,14/191,435/18670,0.000161441,0.011444769,0.0097936,PF4/TSC22D3/RUNX3/ZBTB16/HES1/THBS1/PPARG/CD68/CD84/TAL1/LILRB2/COL3A1/PDCD1/CTLA4,14
GO:1900046,GO:1900046,regulation of hemostasis,6/191,80/18670,0.000169934,0.011790531,0.010089477,THBS1/APOE/HPSE/TBXA2R/CAV1/F12,6
GO:0007596,GO:0007596,blood coagulation,12/191,336/18670,0.000185016,0.012569556,0.01075611,PF4/THBS1/F13A1/APOE/HPSE/TBXA2R/CAV1/COL3A1/FBLN1/GNA11/F12/DGKI,12
GO:0050900,GO:0050900,leukocyte migration,15/191,499/18670,0.000198321,0.013198472,0.011294291,PF4/THBS1/CD84/FN1/SCG2/BST1/CSF3R/DYSF/PDE4B/S100A12/CAV1/CEACAM5/CXCL13/SLC7A10/IL17RA,15
GO:0007599,GO:0007599,hemostasis,12/191,341/18670,0.000211964,0.013396999,0.011464176,PF4/THBS1/F13A1/APOE/HPSE/TBXA2R/CAV1/COL3A1/FBLN1/GNA11/F12/DGKI,12
GO:1990266,GO:1990266,neutrophil migration,7/191,118/18670,0.000212831,0.013396999,0.011464176,PF4/BST1/CSF3R/DYSF/PDE4B/S100A12/CXCL13,7
GO:0043271,GO:0043271,negative regulation of ion transport,8/191,157/18670,0.000216115,0.013396999,0.011464176,KCNH2/THBS1/MAOB/DYSF/LILRB2/RRAD/CAV1/NTSR1,8
GO:0050817,GO:0050817,coagulation,12/191,342/18670,0.000217737,0.013396999,0.011464176,PF4/THBS1/F13A1/APOE/HPSE/TBXA2R/CAV1/COL3A1/FBLN1/GNA11/F12/DGKI,12
GO:0050818,GO:0050818,regulation of coagulation,6/191,84/18670,0.000222237,0.013420643,0.011484409,THBS1/APOE/HPSE/TBXA2R/CAV1/F12,6
GO:0060291,GO:0060291,long-term synaptic potentiation,6/191,86/18670,0.000252749,0.014985738,0.012823704,VAMP2/APOE/LILRB2/MME/NFATC4/ADCY1,6
GO:2000146,GO:2000146,negative regulation of cell motility,12/191,349/18670,0.000262033,0.015258766,0.013057341,MEF2C/ABHD2/THBS1/PPARG/TACSTD2/VASH1/APOE/TBXA2R/COL3A1/FBLN1/TPM1/CXCL13,12
GO:0007616,GO:0007616,long-term memory,4/191,32/18670,0.000305022,0.016681925,0.014275176,CTNS/APOE/NFATC4/ADCY1,4
GO:0071559,GO:0071559,response to transforming growth factor beta,10/191,255/18670,0.000305835,0.016681925,0.014275176,MEF2C/ZEB1/RUNX3/THBS1/HPGD/CAV1/COL3A1/BAMBI/SMAD1/SMAD2,10
GO:0060326,GO:0060326,cell chemotaxis,11/191,304/18670,0.000306935,0.016681925,0.014275176,PF4/THBS1/SCG2/BST1/CSF3R/DYSF/PDE4B/S100A12/CXCL13/HBEGF/IL17RA,11
GO:1903037,GO:1903037,regulation of leukocyte cell-cell adhesion,11/191,304/18670,0.000306935,0.016681925,0.014275176,EBI3/RUNX3/ZBTB16/CD209/HES1/LILRB2/CAV1/IGF2/CYLD/PDCD1/CTLA4,11
GO:0036295,GO:0036295,cellular response to increased oxygen levels,3/191,14/18670,0.000353062,0.01827767,0.015640698,PPARG/ATG7/CAV1,3
GO:0048660,GO:0048660,regulation of smooth muscle cell proliferation,8/191,169/18670,0.000355774,0.01827767,0.015640698,MEF2C/SF1/THBS1/PPARG/HPGD/TPM1/FOXP1/HBEGF,8
GO:0090130,GO:0090130,tissue migration,12/191,361/18670,0.000355837,0.01827767,0.015640698,MEF2C/THBS1/PPARG/TACSTD2/VASH1/APOE/SCG2/TBXA2R/ACTG2/FOXP1/CXCL13/HBEGF,12
GO:0010876,GO:0010876,lipid localization,13/191,415/18670,0.000358715,0.01827767,0.015640698,ABCB4/OSBPL10/ACACB/THBS1/PPARG/APOE/GM2A/SCARB2/DYSF/PLA2G6/CAV1/NTSR1/ATP9A,13
GO:0006936,GO:0006936,muscle contraction,12/191,363/18670,0.00037395,0.018460756,0.015797371,KCNH2/DYSF/PDE4B/PLA2G6/TBXA2R/ACTG2/CALD1/CAV1/MYH11/MYLK/TPM1/SLC6A8,12
GO:0015850,GO:0015850,organic hydroxy compound transport,10/191,262/18670,0.000378914,0.018460756,0.015797371,ABCB4/OSBPL10/SLC16A7/PPARG/SLC26A6/SYT17/APOE/MAOB/SLC18A2/CAV1,10
GO:0050671,GO:0050671,positive regulation of lymphocyte proliferation,7/191,130/18670,0.000384823,0.018460756,0.015797371,EBI3/MEF2C/CD209/HES1/BST1/LILRB2/IGF2,7
GO:0048659,GO:0048659,smooth muscle cell proliferation,8/191,171/18670,0.000384953,0.018460756,0.015797371,MEF2C/SF1/THBS1/PPARG/HPGD/TPM1/FOXP1/HBEGF,8
GO:0032946,GO:0032946,positive regulation of mononuclear cell proliferation,7/191,131/18670,0.000403086,0.019050184,0.01630176,EBI3/MEF2C/CD209/HES1/BST1/LILRB2/IGF2,7
GO:0035909,GO:0035909,aorta morphogenesis,4/191,35/18670,0.00043363,0.020117643,0.017215214,HES1/COL3A1/MYLK/HEY1,4
GO:1901841,GO:1901841,regulation of high voltage-gated calcium channel activity,3/191,15/18670,0.000438011,0.020117643,0.017215214,DYSF/PDE4B/RRAD,3
GO:0001936,GO:0001936,regulation of endothelial cell proliferation,8/191,176/18670,0.000466504,0.021128735,0.018080433,MEF2C/THBS1/PPARG/VASH1/APOE/SCG2/DYSF/CAV1,8
GO:0015908,GO:0015908,fatty acid transport,6/191,97/18670,0.000484204,0.021394683,0.018308012,ACACB/THBS1/PPARG/APOE/PLA2G6/NTSR1,6
GO:0051249,GO:0051249,regulation of lymphocyte activation,14/191,485/18670,0.000485497,0.021394683,0.018308012,EBI3/MEF2C/ZEB1/RUNX3/ZBTB16/CD209/HES1/BST1/LILRB2/CAV1/IGF2/CYLD/PDCD1/CTLA4,14
GO:1903034,GO:1903034,regulation of response to wounding,8/191,179/18670,0.000521813,0.0224339,0.019197298,THBS1/APOE/HPSE/TBXA2R/CAV1/MYLK/F12/HBEGF,8
GO:0061448,GO:0061448,connective tissue development,10/191,273/18670,0.000522839,0.0224339,0.019197298,MEF2C/ZEB1/RUNX3/ZBTB16/LRP5L/CTSK/MGP/NFIB/ATF2/SMAD1,10
GO:2001257,GO:2001257,regulation of cation channel activity,8/191,180/18670,0.000541387,0.022928111,0.019620208,MEF2C/VAMP2/DYSF/PDE4B/PLA2G6/RRAD/CAV1/NTSR1,8
GO:0006869,GO:0006869,lipid transport,12/191,380/18670,0.000561963,0.023169536,0.019826801,ABCB4/OSBPL10/ACACB/THBS1/PPARG/APOE/GM2A/SCARB2/PLA2G6/CAV1/NTSR1/ATP9A,12
GO:0060840,GO:0060840,artery development,6/191,100/18670,0.000569541,0.023169536,0.019826801,HES1/APOE/HPGD/COL3A1/MYLK/HEY1,6
GO:0040013,GO:0040013,negative regulation of locomotion,12/191,381/18670,0.000575136,0.023169536,0.019826801,MEF2C/ABHD2/THBS1/PPARG/TACSTD2/VASH1/APOE/TBXA2R/COL3A1/FBLN1/TPM1/CXCL13,12
GO:0070665,GO:0070665,positive regulation of leukocyte proliferation,7/191,139/18670,0.000575508,0.023169536,0.019826801,EBI3/MEF2C/CD209/HES1/BST1/LILRB2/IGF2,7
GO:0001822,GO:0001822,kidney development,10/191,278/18670,0.000601848,0.02378372,0.020352376,MEF2C/ZBTB16/HES1/TIPARP/TACSTD2/HPGD/MME/SMAD1/AHI1/SMAD2,10
GO:0001655,GO:0001655,urogenital system development,11/191,330/18670,0.000610942,0.02378372,0.020352376,MEF2C/ZBTB16/HES1/TIPARP/TACSTD2/HPGD/MME/FKBP4/SMAD1/AHI1/SMAD2,11
GO:0051271,GO:0051271,negative regulation of cellular component movement,12/191,384/18670,0.000616223,0.02378372,0.020352376,MEF2C/ABHD2/THBS1/PPARG/TACSTD2/VASH1/APOE/TBXA2R/COL3A1/FBLN1/TPM1/CXCL13,12
GO:0009743,GO:0009743,response to carbohydrate,9/191,230/18670,0.000619938,0.02378372,0.020352376,VAMP2/LRP5L/THBS1/SLC26A6/ATG7/ME1/PLA2G6/VSNL1/SMAD2,9
GO:0050665,GO:0050665,hydrogen peroxide biosynthetic process,3/191,17/18670,0.000644815,0.024450494,0.020922952,CTNS/CYBB/MAOB,3
GO:0034766,GO:0034766,negative regulation of ion transmembrane transport,6/191,103/18670,0.000666128,0.024918423,0.021323372,KCNH2/THBS1/DYSF/RRAD/CAV1/NTSR1,6
GO:0030336,GO:0030336,negative regulation of cell migration,11/191,334/18670,0.000674774,0.024918423,0.021323372,MEF2C/ABHD2/THBS1/PPARG/TACSTD2/VASH1/APOE/TBXA2R/COL3A1/TPM1/CXCL13,11
GO:0097305,GO:0097305,response to alcohol,9/191,233/18670,0.00068008,0.024918423,0.021323372,KLF9/PPARG/CYBB/HPGD/MAOB/TBXA2R/LRP8/ADCY1/SMAD2,9
GO:0032409,GO:0032409,regulation of transporter activity,10/191,283/18670,0.000690493,0.024930151,0.021333408,MEF2C/VAMP2/PPARG/DYSF/PDE4B/PLA2G6/RRAD/CAV1/NTSR1/SYNGR3,10
GO:0048167,GO:0048167,regulation of synaptic plasticity,8/191,187/18670,0.00069569,0.024930151,0.021333408,MEF2C/VAMP2/APOE/LILRB2/MME/NFATC4/DGKI/ADCY1,8
GO:0007159,GO:0007159,leukocyte cell-cell adhesion,11/191,337/18670,0.000726214,0.025741146,0.022027398,EBI3/RUNX3/ZBTB16/CD209/HES1/LILRB2/CAV1/IGF2/CYLD/PDCD1/CTLA4,11
GO:0001935,GO:0001935,endothelial cell proliferation,8/191,191/18670,0.000798655,0.028004465,0.023964182,MEF2C/THBS1/PPARG/VASH1/APOE/SCG2/DYSF/CAV1,8
GO:0033002,GO:0033002,muscle cell proliferation,9/191,239/18670,0.000814696,0.028263011,0.024185427,MEF2C/SF1/THBS1/PPARG/HPGD/TPM1/FOXP1/SMAD1/HBEGF,9
GO:0010632,GO:0010632,regulation of epithelial cell migration,10/191,291/18670,0.000854585,0.029334749,0.025102542,MEF2C/THBS1/PPARG/TACSTD2/VASH1/APOE/TBXA2R/FOXP1/CXCL13/HBEGF,10
GO:0072001,GO:0072001,renal system development,10/191,293/18670,0.000900264,0.030429067,0.02603898,MEF2C/ZBTB16/HES1/TIPARP/TACSTD2/HPGD/MME/SMAD1/AHI1/SMAD2,10
GO:0060716,GO:0060716,labyrinthine layer blood vessel development,3/191,19/18670,0.000905127,0.030429067,0.02603898,HES1/VASH1/HEY1,3
GO:0022407,GO:0022407,regulation of cell-cell adhesion,12/191,402/18670,0.000918052,0.030548657,0.026141316,EBI3/RUNX3/ZBTB16/CD209/HES1/LILRB2/CAV1/IGF2/CYLD/CXCL13/PDCD1/CTLA4,12
GO:0051145,GO:0051145,smooth muscle cell differentiation,5/191,74/18670,0.000967546,0.031870372,0.027272343,MEF2C/ZEB1/HES1/NFATC4/HEY1,5
GO:0042110,GO:0042110,T cell activation,13/191,464/18670,0.001011946,0.03299957,0.028238629,EBI3/ZEB1/RUNX3/ZBTB16/CD209/HES1/LILRB2/CAV1/IGF2/CYLD/FOXP1/PDCD1/CTLA4,13
GO:0010631,GO:0010631,epithelial cell migration,11/191,352/18670,0.001034921,0.033139061,0.028357995,MEF2C/THBS1/PPARG/TACSTD2/VASH1/APOE/SCG2/TBXA2R/FOXP1/CXCL13/HBEGF,11
GO:0007179,GO:0007179,transforming growth factor beta receptor signaling pathway,8/191,199/18670,0.00104132,0.033139061,0.028357995,ZEB1/THBS1/HPGD/CAV1/COL3A1/BAMBI/SMAD1/SMAD2,8
GO:0002577,GO:0002577,regulation of antigen processing and presentation,3/191,20/18670,0.001056873,0.033139061,0.028357995,THBS1/CD68/LILRB2,3
GO:0048745,GO:0048745,smooth muscle tissue development,3/191,20/18670,0.001056873,0.033139061,0.028357995,TIPARP/COL3A1/MYLK,3
GO:0071560,GO:0071560,cellular response to transforming growth factor beta stimulus,9/191,249/18670,0.001086782,0.033752342,0.028882796,MEF2C/ZEB1/THBS1/HPGD/CAV1/COL3A1/BAMBI/SMAD1/SMAD2,9
GO:0001505,GO:0001505,regulation of neurotransmitter levels,11/191,355/18670,0.001108113,0.033771564,0.028899245,MEF2C/VAMP2/SYNJ1/SYT17/MAOB/SLC18A2/CAV1/NTSR1/DGKI/SYNGR3/ADCY1,11
GO:0090132,GO:0090132,epithelium migration,11/191,355/18670,0.001108113,0.033771564,0.028899245,MEF2C/THBS1/PPARG/TACSTD2/VASH1/APOE/SCG2/TBXA2R/FOXP1/CXCL13/HBEGF,11
GO:1905952,GO:1905952,regulation of lipid localization,7/191,156/18670,0.001135525,0.033980593,0.029078117,ABCB4/ACACB/THBS1/PPARG/APOE/PLA2G6/NTSR1,7
GO:1900271,GO:1900271,regulation of long-term synaptic potentiation,4/191,45/18670,0.001139522,0.033980593,0.029078117,APOE/LILRB2/MME/ADCY1,4
GO:0009746,GO:0009746,response to hexose,8/191,202/18670,0.001146233,0.033980593,0.029078117,VAMP2/LRP5L/THBS1/SLC26A6/ATG7/PLA2G6/VSNL1/SMAD2,8
GO:0003012,GO:0003012,muscle system process,13/191,472/18670,0.001180819,0.034690546,0.029685643,MEF2C/KCNH2/DYSF/PDE4B/PLA2G6/TBXA2R/ACTG2/CALD1/CAV1/MYH11/MYLK/TPM1/SLC6A8,13
GO:0017000,GO:0017000,antibiotic biosynthetic process,3/191,21/18670,0.00122378,0.035098998,0.030035166,CTNS/CYBB/MAOB,3
GO:0055093,GO:0055093,response to hyperoxia,3/191,21/18670,0.00122378,0.035098998,0.030035166,PPARG/ATG7/CAV1,3
GO:0043407,GO:0043407,negative regulation of MAP kinase activity,5/191,78/18670,0.001227012,0.035098998,0.030035166,DUSP2/APOE/DUSP4/CAV1/DUSP5,5
GO:0051924,GO:0051924,regulation of calcium ion transport,9/191,254/18670,0.001248102,0.035102325,0.030038014,CD84/DYSF/LILRB2/PDE4B/PLA2G6/RRAD/CAV1/MYLK/NTSR1,9
GO:1903706,GO:1903706,regulation of hemopoiesis,13/191,475/18670,0.001249936,0.035102325,0.030038014,MEF2C/PF4/ZEB1/RUNX3/ZBTB16/HES1/THBS1/TAL1/CSF3R/LILRB2/CYLD/FOXP1/CTLA4,13
GO:0071222,GO:0071222,cellular response to lipopolysaccharide,8/191,205/18670,0.001259421,0.035102325,0.030038014,MEF2C/PF4/CD68/SGMS1/LILRB2/PDE4B/TBXA2R/CXCL13,8
GO:0034284,GO:0034284,response to monosaccharide,8/191,207/18670,0.001339704,0.036792907,0.031484691,VAMP2/LRP5L/THBS1/SLC26A6/ATG7/PLA2G6/VSNL1/SMAD2,8
GO:0061614,GO:0061614,pri-miRNA transcription by RNA polymerase II,4/191,47/18670,0.001342642,0.036792907,0.031484691,PPARG/NFIB/NFATC4/SMAD1,4
GO:0050670,GO:0050670,regulation of lymphocyte proliferation,8/191,208/18670,0.001381345,0.037538045,0.032122325,EBI3/MEF2C/CD209/HES1/BST1/LILRB2/IGF2/CTLA4,8
GO:0032944,GO:0032944,regulation of mononuclear cell proliferation,8/191,209/18670,0.001424009,0.03806305,0.032571586,EBI3/MEF2C/CD209/HES1/BST1/LILRB2/IGF2/CTLA4,8
GO:0051216,GO:0051216,cartilage development,8/191,209/18670,0.001424009,0.03806305,0.032571586,MEF2C/ZEB1/RUNX3/ZBTB16/CTSK/MGP/NFIB/SMAD1,8
GO:0034765,GO:0034765,regulation of ion transmembrane transport,13/191,483/18670,0.001450945,0.038467748,0.032917897,MEF2C/SCN3A/VAMP2/KCNH2/THBS1/CYBB/DYSF/KCNJ15/PDE4B/PLA2G6/RRAD/CAV1/NTSR1,13
GO:1905954,GO:1905954,positive regulation of lipid localization,5/191,82/18670,0.00153465,0.040358832,0.034536149,ABCB4/ACACB/APOE/PLA2G6/NTSR1,5
GO:0071219,GO:0071219,cellular response to molecule of bacterial origin,8/191,212/18670,0.001558317,0.040627183,0.034765785,MEF2C/PF4/CD68/SGMS1/LILRB2/PDE4B/TBXA2R/CXCL13,8
GO:2001238,GO:2001238,positive regulation of extrinsic apoptotic signaling pathway,4/191,49/18670,0.001569772,0.040627183,0.034765785,THBS1/G0S2/CAV1/CYLD,4
GO:0072337,GO:0072337,modified amino acid transport,3/191,23/18670,0.001605248,0.040901198,0.035000267,CTNS/SLC22A4/SLC6A8,3
GO:1903409,GO:1903409,reactive oxygen species biosynthetic process,6/191,122/18670,0.001605444,0.040901198,0.035000267,CTNS/CYBB/MAOB/MPO/SLC18A2/CAV1,6
GO:0051098,GO:0051098,regulation of binding,11/191,373/18670,0.001642532,0.04152168,0.03553123,MEF2C/HES1/PPARG/APOE/MAPRE3/CAV1/BAMBI/CYLD/NFATC4/HEY1/SMAD2,11
GO:1903793,GO:1903793,positive regulation of anion transport,4/191,50/18670,0.001692787,0.042462915,0.03633667,ABCB4/APOE/PLA2G6/NTSR1,4
GO:0050806,GO:0050806,positive regulation of synaptic transmission,7/191,168/18670,0.001739407,0.043299293,0.037052382,VAMP2/APOE/LILRB2/MME/NTSR1/NFATC4/ADCY1,7
GO:0032368,GO:0032368,regulation of lipid transport,6/191,125/18670,0.001816765,0.044882342,0.03840704,ABCB4/THBS1/PPARG/APOE/PLA2G6/NTSR1,6
GO:0007269,GO:0007269,neurotransmitter secretion,7/191,170/18670,0.001860565,0.045278374,0.038745935,MEF2C/VAMP2/SYNJ1/SYT17/SLC18A2/DGKI/ADCY1,7
GO:0099643,GO:0099643,signal release from synapse,7/191,170/18670,0.001860565,0.045278374,0.038745935,MEF2C/VAMP2/SYNJ1/SYT17/SLC18A2/DGKI/ADCY1,7
GO:1902105,GO:1902105,regulation of leukocyte differentiation,9/191,272/18670,0.001996079,0.047983685,0.041060944,PF4/ZEB1/RUNX3/ZBTB16/TAL1/LILRB2/CYLD/FOXP1/CTLA4,9
GO:0048545,GO:0048545,response to steroid hormone,11/191,383/18670,0.002020637,0.047983685,0.041060944,KLF9/ABHD2/THBS1/PPARG/CYBB/MAOB/ALPL/CAV1/FKBP4/FOXP1/DDX17,11
GO:0034763,GO:0034763,negative regulation of transmembrane transport,6/191,128/18670,0.002048537,0.047983685,0.041060944,KCNH2/THBS1/DYSF/RRAD/CAV1/NTSR1,6
GO:1905809,GO:1905809,negative regulation of synapse organization,3/191,25/18670,0.002053667,0.047983685,0.041060944,APOE/LILRB2/NFATC4,3
GO:0016525,GO:0016525,negative regulation of angiogenesis,7/191,173/18670,0.002054467,0.047983685,0.041060944,PF4/EPN2/THBS1/PPARG/VASH1/TBXA2R/ATF2,7
GO:0070663,GO:0070663,regulation of leukocyte proliferation,8/191,222/18670,0.002080056,0.047983685,0.041060944,EBI3/MEF2C/CD209/HES1/BST1/LILRB2/IGF2/CTLA4,8
GO:0043542,GO:0043542,endothelial cell migration,9/191,274/18670,0.002097531,0.047983685,0.041060944,MEF2C/THBS1/PPARG/VASH1/APOE/SCG2/TBXA2R/FOXP1/CXCL13,9
GO:0031638,GO:0031638,zymogen activation,4/191,53/18670,0.002101767,0.047983685,0.041060944,THBS1/C1R/F12/GGT1,4
GO:0042692,GO:0042692,muscle cell differentiation,11/191,385/18670,0.00210416,0.047983685,0.041060944,MEF2C/ZEB1/HES1/DYSF/LDB3/CEACAM5/MYH11/TPM1/IGF2/NFATC4/HEY1,11
GO:2000181,GO:2000181,negative regulation of blood vessel morphogenesis,7/191,175/18670,0.002192181,0.049576048,0.042423572,PF4/EPN2/THBS1/PPARG/VASH1/TBXA2R/ATF2,7
GO:0097306,GO:0097306,cellular response to alcohol,5/191,89/18670,0.002204393,0.049576048,0.042423572,KLF9/PPARG/CYBB/LRP8/ADCY1,5